These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10907028)
1. [Uremic middle molecules in chronic renal insufficiency]. Matulewicz-Gilewicz J; Popławski A Pol Merkur Lekarski; 1997 Jan; 2(9):199-200. PubMed ID: 10907028 [TBL] [Abstract][Full Text] [Related]
2. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119 [TBL] [Abstract][Full Text] [Related]
3. Uremic toxicity and anemia. Bonomini M; Sirolli V J Nephrol; 2003; 16(1):21-8. PubMed ID: 12649531 [TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis. Al-Hashimi AF; Mohammed FH; Al-Khazragi AS Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763 [TBL] [Abstract][Full Text] [Related]
5. Uremic pruritus in the chronic renal failure patients. Chodorowska G; Wysokiński A; Chodorowski J Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):174-9. PubMed ID: 16145975 [TBL] [Abstract][Full Text] [Related]
6. [Changes in the nervous system before and after kidney transplantation in patients with chronic renal insufficiency]. Bogolepov NK; Lopatkin NA; Aristova RA Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(11):1639-48. PubMed ID: 4905366 [No Abstract] [Full Text] [Related]
7. Uremic syndrome and end-stage renal disease: physical manifestations and beyond. Chikotas N; Gunderman A; Oman T J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706 [TBL] [Abstract][Full Text] [Related]
8. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743 [TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
11. [Urinary excretion of glycosaminoglycans in patients with chronic pyelonephritis and chronic glomerulonephritis]. Pavlov SB Klin Med (Mosk); 1998; 76(2):41-3. PubMed ID: 9553361 [TBL] [Abstract][Full Text] [Related]
12. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241 [TBL] [Abstract][Full Text] [Related]
13. [Conformity of clinical and pathological-anatomical diagnosis in terminal kidney failure]. Osten B; Osten E; Kaeding A; Klinkmann H; Tessmann D Z Gesamte Inn Med; 1973 Jan; 28(1):15-7. PubMed ID: 4694330 [No Abstract] [Full Text] [Related]
14. Oxalic Acid as a uremic toxin. Mydlík M; Derzsiová K J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441 [TBL] [Abstract][Full Text] [Related]
15. [Influence of renal transplantation on uremic polyneuropathy]. Valli G; Schönhuber R; Freschi R Riv Neurol; 1974; 44(3):196-204. PubMed ID: 4610689 [No Abstract] [Full Text] [Related]
16. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Valli A; Suliman ME; Meert N; Vanholder R; Lindholm B; Stenvinkel P; Watanabe M; Barany P; Alvestrand A; Anderstam B Clin Chim Acta; 2007 Apr; 379(1-2):87-94. PubMed ID: 17292872 [TBL] [Abstract][Full Text] [Related]